Cargando…
Time to stop using hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma?—the SCOOP-2 trial experience
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723635/ https://www.ncbi.nlm.nih.gov/pubmed/33313085 http://dx.doi.org/10.21037/atm-2020-96 |
| _version_ | 1783620382906908672 |
|---|---|
| author | Peck-Radosavljevic, Markus Bota, Simona Hucke, Florian |
| author_facet | Peck-Radosavljevic, Markus Bota, Simona Hucke, Florian |
| author_sort | Peck-Radosavljevic, Markus |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7723635 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77236352020-12-10 Time to stop using hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma?—the SCOOP-2 trial experience Peck-Radosavljevic, Markus Bota, Simona Hucke, Florian Ann Transl Med Editorial Commentary AME Publishing Company 2020-11 /pmc/articles/PMC7723635/ /pubmed/33313085 http://dx.doi.org/10.21037/atm-2020-96 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Peck-Radosavljevic, Markus Bota, Simona Hucke, Florian Time to stop using hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma?—the SCOOP-2 trial experience |
| title | Time to stop using hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma?—the SCOOP-2 trial experience |
| title_full | Time to stop using hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma?—the SCOOP-2 trial experience |
| title_fullStr | Time to stop using hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma?—the SCOOP-2 trial experience |
| title_full_unstemmed | Time to stop using hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma?—the SCOOP-2 trial experience |
| title_short | Time to stop using hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma?—the SCOOP-2 trial experience |
| title_sort | time to stop using hepatic arterial infusion chemotherapy (haic) for advanced hepatocellular carcinoma?—the scoop-2 trial experience |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723635/ https://www.ncbi.nlm.nih.gov/pubmed/33313085 http://dx.doi.org/10.21037/atm-2020-96 |
| work_keys_str_mv | AT peckradosavljevicmarkus timetostopusinghepaticarterialinfusionchemotherapyhaicforadvancedhepatocellularcarcinomathescoop2trialexperience AT botasimona timetostopusinghepaticarterialinfusionchemotherapyhaicforadvancedhepatocellularcarcinomathescoop2trialexperience AT huckeflorian timetostopusinghepaticarterialinfusionchemotherapyhaicforadvancedhepatocellularcarcinomathescoop2trialexperience |